NAP1L1 and hypertrophic cardiomyopathy: Given that fibrosis is a common feature in both ischemic and hypertrophic cardiomyopathy, the interaction of NAP1L1 with pathways regulating cardiac remodeling, such as YAP1, may be relevant.